Opinion
Video
Initial Treatment Strategies for Polycythemia Vera
Author(s):
Panelists discuss how they approach the evaluation and diagnosis of polycythemia vera (PV), including key clinical manifestations, and how they assess disease risk to determine initial treatment strategies based on NCCN guidelines, considering factors that differentiate low-risk from high-risk PV.
Video content above is prompted by the following:
- Briefly provide an overview of PV and pathobiology.
- What clinical manifestations best inform your evaluation and diagnosis of PV?
2. Please comment on disease risk and initial therapy for patients with PV.
- What key factors do you consider when assessing low- versus high-risk PV?
- What is your initial treatment strategy for patients with PV?
Related Videos
Related Content
